Olivia Kim-McManus, MD
University of California, San Diego and Rady Children's Institute for Genomic Medicine
Dr. Olivia Kim-McManus has expertise in diagnosis and treatment of pediatric neurogenetic conditions in infants and children with epileptic encephalopathy and neurodevelopmental disorders. She is an Associate Clinical Professor of Neurosciences at UCSD with Board certifications in Neurology, Epilepsy, Clinical Neurophysiology, and physician scientist at the Rady Children’s Institute for Genomic Medicine with experience in development, institutional implementation, and delivery of novel targeted genetic therapeutics for rare causal variants. She is PI for a first in-human investigator-initiated clinical trial for individualized allele-specific antisense oligonucleotide (ASO) in SCN2A, and other current and upcoming investigator-initiated and industry sponsored genetic therapy studies. She serves on Advisory Boards including Epilepsy Foundation San Diego and a member of N=1 Collaborative and Child Neurology Society Research Committee.